VITASPRING BIOMEDICAL CO., LTD. Accrued Investment Income Receivable
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Accrued Investment Income Receivable of $14.53 thousand as of 2018-10-31, per its 10-Q filed 2018-11-21.
Discontinued › Balance Sheet › Assets
us-gaap:AccruedInvestmentIncomeReceivable · last filed 2018-11-21
- 2018-10-31: Accrued Investment Income Receivable $14.53K.
| Period end | Accrued Investment Income Receivable |
|---|---|
| 2018-10-31 | $14.53K 10-Q · filed 2018-11-21 |